Jianmin Pharmaceutical Group Co Ltd Cash Flow Conversion Efficiency
Jianmin Pharmaceutical Group Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Jianmin Pharmaceutical Group Co Ltd (600976) has a cash flow conversion efficiency ratio of 0.039x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥106.82 Million ≈ $15.63 Million USD) by net assets (CN¥2.72 Billion ≈ $398.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Jianmin Pharmaceutical Group Co Ltd (2003–2025)
Cash flow conversion efficiency of Jianmin Pharmaceutical Group Co Ltd from 2003 to 2025. This chart illustrates how Jianmin Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Jianmin Pharmaceutical Group Co Ltd (600976) stock price for real-time trading data and today's change.
Jianmin Pharmaceutical Group Co Ltd Cash Flow Conversion Ratio Explained
Jianmin Pharmaceutical Group Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Jianmin Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jianmin Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency. Also see 600976 company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shenzhen Minglida Precision Technology Co. Ltd.
SHE:301268
|
N/A |
|
Changzhou Galaxy Century Microelectronics Co Ltd
SHG:688689
|
0.006x |
|
Tamar Petroleum Ltd
TA:TMRP
|
0.237x |
|
MFA Financial Inc
NYSE:MFA
|
0.073x |
|
HomeTrust Bancshares, Inc.
NASDAQ:HTB
|
0.127x |
|
Nanjing Chemical Fibre Co Ltd
SHG:600889
|
-0.100x |
|
Sheela Foam Limited
NSE:SFL
|
0.036x |
|
Marimaca Copper Corp.
AU:MC2
|
0.000x |
Annual Cash Flow Conversion Efficiency for Jianmin Pharmaceutical Group Co Ltd (2003–2025)
The table below shows the annual cash flow conversion efficiency of Jianmin Pharmaceutical Group Co Ltd from 2003 to 2025. Review how much free cash does Jianmin Pharmaceutical Group Co Ltd generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.72 Billion ≈ $398.20 Million |
CN¥274.53 Million ≈ $40.17 Million |
0.101x | +5.52% |
| 2024-12-31 | CN¥2.45 Billion ≈ $358.56 Million |
CN¥234.27 Million ≈ $34.28 Million |
0.096x | -19.62% |
| 2023-12-31 | CN¥2.26 Billion ≈ $330.19 Million |
CN¥268.39 Million ≈ $39.27 Million |
0.119x | +2.92% |
| 2022-12-31 | CN¥1.87 Billion ≈ $273.32 Million |
CN¥215.87 Million ≈ $31.59 Million |
0.116x | -30.07% |
| 2021-12-31 | CN¥1.57 Billion ≈ $229.48 Million |
CN¥259.18 Million ≈ $37.93 Million |
0.165x | +74.20% |
| 2020-12-31 | CN¥1.32 Billion ≈ $193.63 Million |
CN¥125.54 Million ≈ $18.37 Million |
0.095x | +53.92% |
| 2019-12-31 | CN¥1.21 Billion ≈ $176.76 Million |
CN¥74.45 Million ≈ $10.89 Million |
0.062x | +10.97% |
| 2018-12-31 | CN¥1.15 Billion ≈ $167.56 Million |
CN¥63.60 Million ≈ $9.31 Million |
0.056x | +74.75% |
| 2017-12-31 | CN¥1.11 Billion ≈ $162.05 Million |
CN¥35.20 Million ≈ $5.15 Million |
0.032x | -71.21% |
| 2016-12-31 | CN¥1.03 Billion ≈ $150.92 Million |
CN¥113.84 Million ≈ $16.66 Million |
0.110x | +127.22% |
| 2015-12-31 | CN¥997.36 Million ≈ $145.94 Million |
CN¥48.45 Million ≈ $7.09 Million |
0.049x | -52.85% |
| 2014-12-31 | CN¥1.00 Billion ≈ $146.63 Million |
CN¥103.23 Million ≈ $15.11 Million |
0.103x | +113.60% |
| 2013-12-31 | CN¥940.46 Million ≈ $137.62 Million |
CN¥45.36 Million ≈ $6.64 Million |
0.048x | -55.63% |
| 2012-12-31 | CN¥903.10 Million ≈ $132.15 Million |
CN¥98.17 Million ≈ $14.37 Million |
0.109x | +226.20% |
| 2011-12-31 | CN¥876.97 Million ≈ $128.33 Million |
CN¥-75.54 Million ≈ $-11.05 Million |
-0.086x | -148.72% |
| 2010-12-31 | CN¥848.81 Million ≈ $124.21 Million |
CN¥150.08 Million ≈ $21.96 Million |
0.177x | +117.47% |
| 2009-12-31 | CN¥820.32 Million ≈ $120.04 Million |
CN¥66.69 Million ≈ $9.76 Million |
0.081x | -43.79% |
| 2008-12-31 | CN¥761.24 Million ≈ $111.39 Million |
CN¥110.11 Million ≈ $16.11 Million |
0.145x | +1660.69% |
| 2007-12-31 | CN¥742.63 Million ≈ $108.67 Million |
CN¥-6.88 Million ≈ $-1.01 Million |
-0.009x | -112.65% |
| 2006-12-31 | CN¥766.61 Million ≈ $112.18 Million |
CN¥56.18 Million ≈ $8.22 Million |
0.073x | +260.73% |
| 2005-12-31 | CN¥759.65 Million ≈ $111.16 Million |
CN¥-34.63 Million ≈ $-5.07 Million |
-0.046x | -877.87% |
| 2004-12-31 | CN¥705.12 Million ≈ $103.18 Million |
CN¥4.13 Million ≈ $604.74K |
0.006x | -59.37% |
| 2003-12-31 | CN¥290.32 Million ≈ $42.48 Million |
CN¥4.19 Million ≈ $612.80K |
0.014x | -- |
About Jianmin Pharmaceutical Group Co Ltd
Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells traditional Chinese medicines and paediatric products in China. It provides over-the-counter, medical, and general health products in the form of capsules, granules, and gels under the Jianmin, Longmu, and Yekaitai brands. The company was founded in 1637 and is based in Wuhan, China.